Electroceuticals Global Market Report 2024

Electroceuticals constitute a field in medical science and technology that employs electrical stimulation to modulate and engage with the body's neural circuits and bioelectrical systems for therapeutic purposes. This interdisciplinary approach combines electronics, biology, and medical principles to create devices and therapies targeting specific nerves, tissues, or organs, offering treatment for various medical conditions.

The primary categories of electroceuticals include implantable electroceutical devices and non-invasive electroceutical devices. Implantable electroceutical devices are medical devices positioned inside the body to administer electrical stimulation or therapy directly to targeted tissues or organs, enabling precise and localized treatment. The range of products encompasses implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. These devices find application in treating conditions such as arrhythmia, depression, Parkinson's disease, tremor, epilepsy, sensorineural hearing loss, among others, and are utilized by end-users including hospitals, ambulatory surgical centers, diagnostic centers, and others.

The electroceuticals research report is one of a series of new reports from The Business Research Company that provides electroceuticals market statistics, including the electroceuticals industry's global market size, regional shares, competitors with an electroceuticals market share, detailed electroceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the electroceuticals industry. This electroceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The electroceuticals market size has grown strongly in recent years. It will grow from $21.81 billion in 2023 to $23.38 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The historical period's growth can be credited to an increase in chronic diseases, investments in research and development, an aging population, advancements in nanotechnology, and an enhanced understanding of neural pathways.

The electroceuticals market size is expected to see strong growth in the next few years. It will grow to $30.84 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The forecast period's growth can be attributed to progress in bioelectronics, the development of precision medicine, an increase in non-invasive therapies, a focus on chronic pain management, and a rise in neurological disorders. Major trends in the forecast period include implantable bioelectronic devices, wireless and remote-controlled devices, personalized electroceutical therapies, advancements in neural modulation techniques, and bioelectronic devices for metabolic disorders.

The anticipated growth of the electroceuticals market is driven by the high prevalence of chronic diseases. Chronic diseases, characterized by persistent or long-lasting health conditions, are expected to affect a substantial number of individuals aged 50 and older in the United States, reaching 142.66 million by 2050, according to the National Library of Medicine. Electroceuticals play a crucial role in managing chronic diseases, providing personalized neuromodulation, and offering long-term solutions to address treatment resistance.

The electroceuticals market is poised for growth due to the increasing prevalence of neurological disorders. Neurological disorders, affecting the nervous system, impact a significant portion of the global population. According to The European Academy of Neurology, one in three individuals may experience a neurological disorder at some point in their lives. Furthermore, the World Health Organization reports that epilepsy, a prevalent neurological disorder, affects over 50 million people worldwide, with approximately 80% of cases found in low- and middle-income countries. The application of electroceuticals in modulating the nervous system's activity, reducing side effects, and enabling long-term disease management contributes to the market's expansion.

The electroceuticals market is witnessing a key trend marked by the introduction of technologically improved devices. Major companies in the electroceuticals sector are dedicated to enhancing their product portfolios through the incorporation of advanced technologies, aiming to optimize patient experience and treatment outcomes while maintaining a competitive market position. A notable example is Medtronic PLC, an Ireland-based medical technology company, which, in July 2021, unveiled Percept PC. This deep brain stimulation (DBS) system, equipped with BrainSense technology, is a groundbreaking innovation for treating movement disorders such as Parkinson's and epilepsy. The BrainSense capability captures brain signals during therapeutic stimulation, enhancing clinical settings and providing benefits beyond. The ergonomically designed Percept PC device focuses on improved comfort, catering specifically to patients with conditions such as Parkinson's disease, tremors, dystonia, and epilepsy.

Major players in the electroceuticals market are emphasizing innovative treatments, including advanced non-invasive neuromodulation. This form of treatment targets deep brain structural dysfunctions associated with chronic ailments, particularly central nervous system diseases and overactive bladder. Stimvia, a US-based medical technology company, exemplifies this approach with the launch of uris in September 2023. Uris technology stands out for its ability to precisely stimulate specific nerves through novel electrodes placed on the patient's skin, delivering electric signals directly to the brain. Employing peroneal neuromodulation, this technique involves stimulating peripheral nerves connecting the brain and spinal cord to the extremities, showcasing promising outcomes in clinical trials for conditions such as overactive bladder.

In July 2021, Merck KGaA, a Germany-based science and technology company, entered into a partnership with Innervia Bioelectronics. The primary objective of this collaboration is to enhance the energy efficiency of neurostimulators, a significant step toward digitally customized treatment for patients with severe and chronic illnesses, particularly inflammatory disorders. Leveraging the collective expertise of both organizations, the partnership aims to develop bioelectronic medicines addressing unmet medical needs within Merck's therapy areas. Innervia Bioelectronics, a Spain-based medical device company, contributes to this collaborative effort.

Major companies operating in the electroceuticals market report are Abbott Laboratories Inc., Medtronic Public Limited Company, Boston Scientific Corporation, Sonova Holding AG, Biotronik SE & Co. KG, Cochlear Limited, LivaNova PLC, MicroPort Scientific Corporation Limited, MED-EL Elektromedizinische Gerate GmbH, Nevro Corporation, Axonics Modulation Technologies Inc., Oticon Medical, Neuronetics Inc., Nuvectra Corporation, NeuroPace Inc., Second Sight Medical Products Inc., Saluda Medical Pty. Ltd., Stimwave Technologies Incorporated, electroCore Inc., Synapse Biomedical Inc., Soterix Medical Inc., Retina Implant AG, MicroTransponder Inc., Vomaris Innovations Inc., SPR Therapeutics Inc., NeuroSigma Inc., Nexeon MedSystems Inc., BioElectronics Corporation, Setpoint Medical Corporation, Endonovo Therapeutics Inc.

North America was the largest region in the electroceuticals market in 2023. The regions covered in the electroceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electroceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The electroceuticals market consists of revenues earned by entities by providing services, including clinical support, surgical implantation procedures, programming and adjustment of devices, patient monitoring, and post-implantation care. The market value includes the value of related goods sold by the service provider or included within the service offering. The electroceuticals market also includes sales of wearable electroceuticals, electroceutical drug delivery systems, electroceutical sleep devices, and gastric electrical stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electroceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electroceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for electroceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The electroceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Implantable Electroceutical Devices; Non-Invasive Electroceutical Devices
• 2) By Product: Implantable Cardioverter Defibrillators; Cardiac Pacemakers; Cochlear Implants; Spinal Cord Stimulators; Deep Brain Stimulators; Transcutaneous Electrical Nerve Stimulators; Sacral Nerve Stimulators; Vagus Nerve Stimulators; Other Products
• 3) By Application: Arrhythmia; Depression; Parkinson's Disease; Tremor; Epilepsy; Sensorineural Hearing Loss; Other Applications
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
• Companies Mentioned: Abbott Laboratories Inc.; Medtronic Public Limited Company; Boston Scientific Corporation; Sonova Holding AG; Biotronik SE & Co. KG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.